Dietary restriction (DR) is one of the most universal means of extending lifespan. Yet, whether and how DR specifically affects the metabolic changes associated with aging is essentially unknown. Here, we present a comprehensive and unbiased picture of the metabolic variations that take place with age at the whole organism level in Caenorhabditis elegans by using (1)H high-resolution magic-angle spinning (HR-MAS) nuclear magnetic resonance (NMR) analysis of intact worms. We investigate metabolic variations potentially important for lifespan regulation by comparing the metabolic fingerprint of two previously described genetic models of DR, the long-lived eat-2(ad465) and slcf-1(tm2258) worms, as single mutants or in combination with a genetic suppressor of their lifespan phenotype. Our analysis shows that significant changes in metabolite profiles precede the major physiological decline that accompanies aging and that DR protects from some of those metabolic changes. More specifically, low phosphocholine (PCho) correlates with high life expectancy. A mutation in the tumor suppressor gene PTEN/DAF-18, which suppresses the beneficial effects of DR in both C. elegans and mammals, increases both PCho level and choline kinase expression. Furthermore, we show that choline kinase function in the intestine can regulate lifespan. This study highlights the relevance of NMR metabolomic approaches for identifying potential biomarkers of aging.
Dietary restriction (DR) is one of the most universal means of extending lifespan. Yet, whether and how DR specifically affects the metabolic changes associated with aging is essentially unknown. Here, we present a comprehensive and unbiased picture of the metabolic variations that take place with age at the whole organism level in Caenorhabditis elegans by using (1)H high-resolution magic-angle spinning (HR-MAS) nuclear magnetic resonance (NMR) analysis of intact worms. We investigate metabolic variations potentially important for lifespan regulation by comparing the metabolic fingerprint of two previously described genetic models of DR, the long-lived eat-2(ad465) and slcf-1(tm2258) worms, as single mutants or in combination with a genetic suppressor of their lifespan phenotype. Our analysis shows that significant changes in metabolite profiles precede the major physiological decline that accompanies aging and that DR protects from some of those metabolic changes. More specifically, low phosphocholine (PCho) correlates with high life expectancy. A mutation in the tumor suppressor gene PTEN/DAF-18, which suppresses the beneficial effects of DR in both C. elegans and mammals, increases both PCho level and choline kinase expression. Furthermore, we show that choline kinase function in the intestine can regulate lifespan. This study highlights the relevance of NMR metabolomic approaches for identifying potential biomarkers of aging.
It has been known for
decades that dietary restriction (DR) promotes
longevity significantly and delays aging in many species.[1] Yet, how interventions such as DR specifically
affect the metabolic changes associated with aging has not been extensively
studied. In mammals, this approach is restricted to the description
of metabolite concentrations in biofluids or specific tissues, which
provides complementary but partial information on the homeostatic
network of the whole body. Previous studies have investigated the
metabolite profile of animals under DR in mice, rats, dogs, and rhesus
monkeys. Although these previous studies identified discriminating
metabolites between DR- and ad libitum-fed animals, a consensus of
the results can hardly be established. Several factors might account
for these variations, including the type of biofluid analyzed, either
urine[2,3] or plasma,[4−6] and the ad libitum and
DR regimens that vary from one study to another. Moreover, these analyses
were dedicated mainly to the comparison of young animals to very old
ones that represent a heterogeneous population.In this work,
we use the nematode Caenorhabditis
elegans as a model system to investigate the metabolic
changes associated with DR. C. elegans plays an instrumental role in deciphering mechanisms involved in
aging. Previous genetic screens identified mutants that mimic dietary
restriction, and mutations in genes that encode evolutionary conserved
effectors of DR suppress their long-lived phenotype.[7,8] Those mutants thus provide an ideal biological system to further
assess metabolic variations more specifically linked to the beneficial
effect of DR on lifespan. Here, we assess metabolic phenotypes of
whole C. elegans animals by high-resolution
magic angle spinning (HRMAS) nuclear magnetic resonance (NMR) spectroscopy.[9,10] The influence of DR on the metabolic profiles associated with aging
is analyzed using multivariate statistics. Quantification of individual
metabolites for wild-type, long-lived, and short-lived mutants provides
detailed insight into the metabolic perturbations associated with
DR in C. elegans to highlight biomarkers
of aging across genotypes.
Experimental Section
Nematode Strains, Culture
Conditions, and Lifespan Assay
C. elegans strains were cultured at
20 °C on nematode growth media (NGM)[11] agar plates freshly poured and seeded with Escherichia
coli strain OP50 culture. The OLB11 strain, which
allows intestine-specific inactivation of genes by RNAi, was kindly
provided by Olaf Bossinger.[12] Wild-type
Bristol N2, eat-2(ad465) II, and daf-18(e1375) IV strains were provided by the Caenorhabditis Genetics
Center (University of Minnesota). Strain slcf-1(tm2258) and ckb-2(ok1922) mutants were obtained from the C. elegans knockout consortium and outcrossed five
times in our wild-type strain. Promoter::gfp reporter strains BC14636
(B0285.9) were obtained from the British Columbia C.
elegans Gene Expression Consortium.[13]The ckb-2 clone (B0285.9) was purchased
from GeneService Ltd. Bacterial feeding RNAi experiments and lifespan
assays were carried out essentially as described previously.[8] Survival analyses were performed using the Kaplan–Meier
method, and the significance of differences between survival curves
was calculated using the log rank test. The statistical software used
was XLSTAT 2007 and all P-values <0.05 were considered significant.
Sample Preparation for Metabolomics Analysis
To reduce
variation relative to sample preparation or analysis, the assays were
performed on a large number of worms (40 000 worms of each
age in total, split into 1000 worms per analyzed NMR sample) prepared
in at least three independent experiments. For worm amplification
and synchronization, 10 adult worms were allowed to lay eggs, on E. coliOP50-seeded 55 mm NGM plates, for 2–3
h at 20 °C then removed. When F1 worms reached the preadult-L4
stage, 5-fluorouracil (5-FU, Sigma) was added on top of the plate
at a final concentration of 1.30 mg·L–1 (10
μM) so that the eggs laid by the F1 worms do not develop. This
protocol allowed the maintenance of a synchronized F1 population until
old age, while avoiding transferring worms every couple of days to
separate them from their progeny. Synchronized worms were recovered
24 h later (YA stage, i.e., worms with a vulva, characteristic of
the adult stage, but without eggs in the gonad) or 7 days later (A7).
Worm culture synchronization and recovery were set up to recover both
young adult and 7-day-old worms on the same day for all genotypes,
and repeated at least three times. On the day of recovery, 50 plates
for each condition (age/genotype) were washed 5 times in 50 mL of
M9 buffer, separated by 5 min sedimentation steps to get rid of residual
bacteria. Worms were then fixed for 45 min in 1% paraformaldehyde
and then washed five times in distilled water, followed by five washes
in deuterium oxide. Disposable Kel-f inserts (30 mL) with sealing
caps for 4 mm NMR rotors were filled with around 1000 whole worms
and stored at −80 °C until NMR analysis. Samples were
thawed at room temperature 15 min before the NMR experiments.
Whole C. elegans HR-MAS NMR Spectroscopy
C. elegansHR-MAS NMR spectroscopy
was performed as previously described by Blaise et al.[9,10] Spectra were reduced over the chemical range of 0.55–8.75
ppm to 8200 bins (10–3 ppm wide) with integration
of signal intensity. The residual water signal (δ = 4.5–5
ppm), residual methanol signal resulting from the formaldehyde fixation
step (δ = 3.32–3.39 ppm), and a noise area (δ =
5.5–6.5 ppm) were discarded prior to analysis. Spectra were
normalized using the probabilistic quotient normalization approach[14] with a median of all spectra as a reference
spectrum. We applied Pareto scaling on the data set for multivariate
analysis only.Metabolite assignment was completed exploiting
reference data from the literature,[9,25] the HMDB,[15] MMCD,[16] bbiorefcode-2-0-0
(Bruker, GmbH, Rheinstetten, Germany), and Chenomx NMR Suite 7.0 (Chenomx
Inc., Edmonton, Canada) spectral databases.
NMR Data Analysis
Principal component analysis (PCA),[17] was
first conducted in SIMCA P12+ (Umetrics,
Umea, Sweden) and was used to derive the main sources of variance
within the data set, assess sample homogeneity, and exclude biological
or technical outliers. Orthogonal projection to latent structure discriminant
analysis (OPLS-DA) was then performed in MATLAB (The MathWorks Inc.,
Natick, MA) to derive pairwise comparison between the different conditions
(strains and ages).[18]Metabolites
involved in class discrimination were then derived from an univariate
approach based on the statistical recoupling of variables (SRV) analysis
recently described.[19] SRV corresponds to
an automatic binning scheme based on the relationship of covariance
and correlation between consecutive variables, which is followed by
a univariate unpaired two-tailed t test calculated
for each variable under the Benjamini–Yekutieli correction
to cope with multiple testing issues.[20]Statistically significant metabolites found in the previous
analysis
were finally quantified either by direct signal integration, in the
case of nonoverlapping signals, or by computer assisted manual fitting
(deconvolution) of overlapping NMR peaks using the Chenomx NMR Suite
7.0 (Chenomx Inc., Edmonton, Canada). Results were plotted as means
and 95% confidence intervals and p values were calculated
for each pairwise comparison from univariate unpaired two-tailed t tests.
Quantitative Real-Time PCR
Young
adult and 7-day-old
wild-type daf-18(e1375), slcf-1(tm2258), daf-18(e1375), and slcf-1(tm2258) mutant worms were synchronized in the same conditions as sample
preparation for metabolomic analysis. Biological replicates obtained
from five independent experiments were flash-frozen in liquid N2, and RNA was extracted using the standard Trizol method,
followed by phenol–chloroform purification. Total RNA was quantified
using DO 260 nm on a NanoDrop 1000 spectrophotometer (ThermoScientific,
Baltimore, MA, USA), and quality was assessed with the Agilent 2100
Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). RNA (800 ng)
was spiked with an external control (Poly-A spike control from Bacillus subtilis, Affymetrix) and reverse-transcribed
using the iScript Reverse Transcription Supermix (Bio-Rad, Hercules,
CA, USA). Conventional house-keeping genes, including tba-1, rpl-22, and rpl-26, proved to
be stable between assays and were used for normalization as well as
the external bacterial control and gave similar results. Quantitative
real-time PCR (qRT-PCR) was performed with the Fast SYBR Green Master
Mix and the Applied Biosystems 7900HT Fast Real-Time PCR system (Appied
Biosystems, Foster City, CA, USA). The experimental protocol consisted
of an initial polymerase activation at 95 °C for 20 s, followed
by an amplification program for 40 cycles while maintaining the annealing
and primer extension temperature at 60 °C for 20 min. Melting-curve
analysis was then performed to verify the amplification of a single
product. All primers were designed using NCBI Primer-BLAST and selected
to generate amplicons with a length of 100–200 bp. Standard
curves were generated for each primer set to calculate the efficiency
of each set. Only primer sets with an efficiency of 1.9–2.1
were used for qPCR. The relative mRNA levels for each assay were computed
from the Ct values obtained for the target
gene. qPCR experiments were repeated at least three times using independent
RNA/cDNA preparations. Data were pooled and analyzed using RQ manager
v1.2 and dataAssist v1.0 (Applied Biosystems)
Results and Discussion
Metabolic
Changes Correlate with Both Chronological and Physiological
Age in C. elegans
Wild-type
(WT) worms raised at 20 °C have a median and maximal lifespan
of 17 and 30 days, respectively, on average.[8] Under these experimental conditions, obvious morphological changes
and functional decline appeared after a week and progressively increased
until death.[21] To investigate the metabolic
variations that occur during early adulthood, we analyzed the metabolome
of worms staged at two different adult ages: as young adults (YA)
before egg production starts, and at day 7 of adulthood (A7), just
after egg production ceases. These ages were used to target a time
window preceding the onset of strong morphological alterations while
minimizing the impact of egg production on the metabolome. Acquisition
of 1H NMR metabolic profiles (Figure 1) was performed on a pool of intact fixed animals following HRMAS
protocol described earlier.[10]
Figure 1
Typical 700
MHz 1H HR-MAS NOESY NMR spectrum of whole slcf-1(tm2258)C. elegans worms for aliphatic (δ
= 0.5–5.3 ppm) and aromatic
(δ = 6.5–9 ppm, magnified 5 times) regions. The resolution
of a 1H HR-MAS NMR spectrum is typically 1.3 Hz (measured
as the width at half height for one of the alanine doublet peaks).
Spectra were recorded with a signal-to-noise ratio of 300. Keys: 1,
cyclic fatty acids; 2, lipids (CH3); 3, lipids ((CH2)); 4, lipids (CH2CH2CO); 5, unsaturated lipids (CH2CH=CH);
6, lipids (CH2CO); 7, unsaturated lipids (CH=CHCH2CH=CH); 8, glyceryl of lipids; 9, unsaturated lipids
(CH=CH); PCho, phosphocholine; GPC, glycerophosphocholine.
Typical 700
MHz 1H HR-MAS NOESY NMR spectrum of whole slcf-1(tm2258)C. elegans worms for aliphatic (δ
= 0.5–5.3 ppm) and aromatic
(δ = 6.5–9 ppm, magnified 5 times) regions. The resolution
of a 1HHR-MAS NMR spectrum is typically 1.3 Hz (measured
as the width at half height for one of the alanine doublet peaks).
Spectra were recorded with a signal-to-noise ratio of 300. Keys: 1,
cyclic fatty acids; 2, lipids (CH3); 3, lipids ((CH2)); 4, lipids (CH2CH2CO); 5, unsaturated lipids (CH2CH=CH);
6, lipids (CH2CO); 7, unsaturated lipids (CH=CHCH2CH=CH); 8, glyceryl of lipids; 9, unsaturated lipids
(CH=CH); PCho, phosphocholine; GPC, glycerophosphocholine.Data were analyzed by using two
multivariate statistical approaches:
unsupervised (PCA[17]) or supervised (orthogonal
partial least-squares (OPLS)[18]) models;
the latter extracts a group-specific robust metabolic phenotype by
exploiting the genotype and age class membership within a regression
model. These analyses show that WT YA and A7 worms can clearly be
distinguished by their metabolic fingerprints (Figures 2A–C and 3, Supporting Information (SI) Table S1). YA and A7 worms were
essentially isogenic and maintained in a steady environment, and any
bias linked to individual phenotype is precluded by our sampling conditions.
These data therefore show that metabolic profiles correlate with the
chronological age of adult worms and may constitute a fingerprint
characteristic of physiological aging. In this case, one would expect
that the metabolic profile of worms with extended longevity should
harbor a “young fingerprint “, that is, similar to WT
YA, at a more advanced age. To test this hypothesis, we analyzed the
metabolome of worms carrying a mutation in the slcf-1 gene, which has been shown to increase the average lifespan of animals
by 30% compared with WT animals.[8] Similar
to WT animals, YA and A7 slcf-1(tm2258) mutants can
still be separated according to their metabolic profiles from supervised
analysis (Figure 4A–C). Furthermore,
WT and long-lived worms can also be discriminated at the same chronological
age (YA or A7) (SI Table S2). Indeed, PCA
revealed that the metabolic fingerprint of A7 slcf-1 mutants is closer to the profiles of young adults, either slcf-1(tm2258) or WT, than to the A7 WT fingerprint (Figure 5A).
Figure 2
Metabolic signature of aging in wild-type C. elegans worms. OPLS model discriminating wild-type
young adults and wild-type
adults (1 predictive component and 3 orthogonal components; R2X = 0.846, R2Y = 0.978, Q2 = 0.956) from Pareto-scaled data set: (A) score plot; (B) loadings
plot resulting from the SRV analysis, showing back-scaled OPLS coefficients
values, colored from the original OPLS coefficients if variables were
found statistically significant after a multiple testing univariate
procedure (Benjaminin-Yekutieli correction); and (C) model validation
resulting from 1000 permutations, demonstrating the model robustness,
because model R2 and Q2 values were significantly higher than random model ones.
(D) Score plot of the projections of slcf-1(tm2258) and eat-2(ad465) adults and young adults in the
OPLS model (A), discriminating wild-type adults, and young adults.
Key: 1, cyclic fatty acids; 2, lipids (CH3); 3, lipids ((CH2)); 4, lipids (CH2CH2CO); 5, unsaturated lipids (CH2CH=CH);
6, lipids (CH2CO); 7, unsaturated lipids
(CH=CHCH2CH=CH); 8, glyceryl
of lipids; 9, unsaturated lipids (CH=CH); 10, tyrosine; 11, phenylalanine; 12, formate; PCho,
phosphocholine; GPC, glycerophosphocholine.
Figure 3
Metabolite variations with age in WT, slcf-1(tm2258), eat-2(ad465), daf-18(e1375) mutants,
and daf-18(e1375);slcf-1(tm2258) double mutants and between WT and long-lived mutants slcf-1(tm2258) or eat-2(ad465) in young adults and 7-day-old adults.
a = Increase (green) or decrease (purple) in metabolite concentrations
with age. b = Acetate, lactate, glycerol, and glycine variations are
not reliable due to signal overlaps. c = Increase (green) and decrease
(purple) in metabolite concentrations in long-lived mutant (slcf-1 or eat-2) by comparison to WT. Nonsignificant
metabolite variations are left in gray; YA, young adult; A7, adult.
Figure 4
Metabolic signatures of aging in slcf-1(tm2258) and eat-2(ad465)C. elegans worms. OPLS model discriminating slcf-1(tm2258) young adults and slcf-1(tm2258) adults (1 predictive
component and 3 orthogonal components; R2X = 0.794, R2Y = 0.97, Q2 = 0.934) from Pareto-scaled
data set: (A) scores plot; (B) loadings plot resulting from the SRV
analysis; and (C) model validation resulting from 1000 permutations,
demonstrating the model robustness, because model R2 and Q2 values were significantly
higher than random model ones. OPLS model discriminating eat-2(ad465) young adults and eat-2(ad465) adults (1 predictive
component and 2 orthogonal components; R2X = 0.728, R2Y = 0.978, Q2 = 0.934) from
Pareto-scaled data set: (D) scores plot; (E) corresponding loadings
plot resulting from the SRV analysis; and (F) model validation resulting
from 1000 permutations, demonstrating the model robustness. Key: 1,
cyclic fatty acids; 4, lipids (CH2CH2CO); 5, unsaturated lipids (CH2CH=CH); 6, lipids (CH2CO); 7,
unsaturated lipids (CH=CHCH2CH=CH);
8, glyceryl of lipids; 11, phenylalanine; 12, formate; PCho, phosphocholine;
GPC, glycerophosphocholine.
Figure 5
Metabolic variations in WT, slcf-1(tm2258) and eat-2(ad465) worms during aging. (A) PCA including young
adults and adults WT, slcf-1(tm2258), and eat-2(ad465). PC1 and PC2 stand for the first and second
principal components, respectively. (B) Relative concentrations in
arbitrary units of 22 metabolites and lipid signals corresponding
to specific chemical functions. Results are reported with means and
95% confidence intervals.
Metabolic signature of aging in wild-type C. elegans worms. OPLS model discriminating wild-type
young adults and wild-type
adults (1 predictive component and 3 orthogonal components; R2X = 0.846, R2Y = 0.978, Q2 = 0.956) from Pareto-scaled data set: (A) score plot; (B) loadings
plot resulting from the SRV analysis, showing back-scaled OPLS coefficients
values, colored from the original OPLS coefficients if variables were
found statistically significant after a multiple testing univariate
procedure (Benjaminin-Yekutieli correction); and (C) model validation
resulting from 1000 permutations, demonstrating the model robustness,
because model R2 and Q2 values were significantly higher than random model ones.
(D) Score plot of the projections of slcf-1(tm2258) and eat-2(ad465) adults and young adults in the
OPLS model (A), discriminating wild-type adults, and young adults.
Key: 1, cyclic fatty acids; 2, lipids (CH3); 3, lipids ((CH2)); 4, lipids (CH2CH2CO); 5, unsaturated lipids (CH2CH=CH);
6, lipids (CH2CO); 7, unsaturated lipids
(CH=CHCH2CH=CH); 8, glyceryl
of lipids; 9, unsaturated lipids (CH=CH); 10, tyrosine; 11, phenylalanine; 12, formate; PCho,
phosphocholine; GPC, glycerophosphocholine.Metabolite variations with age in WT, slcf-1(tm2258), eat-2(ad465), daf-18(e1375) mutants,
and daf-18(e1375);slcf-1(tm2258) double mutants and between WT and long-lived mutants slcf-1(tm2258) or eat-2(ad465) in young adults and 7-day-old adults.
a = Increase (green) or decrease (purple) in metabolite concentrations
with age. b = Acetate, lactate, glycerol, and glycine variations are
not reliable due to signal overlaps. c = Increase (green) and decrease
(purple) in metabolite concentrations in long-lived mutant (slcf-1 or eat-2) by comparison to WT. Nonsignificant
metabolite variations are left in gray; YA, young adult; A7, adult.Metabolic signatures of aging in slcf-1(tm2258) and eat-2(ad465)C. elegans worms. OPLS model discriminating slcf-1(tm2258) young adults and slcf-1(tm2258) adults (1 predictive
component and 3 orthogonal components; R2X = 0.794, R2Y = 0.97, Q2 = 0.934) from Pareto-scaled
data set: (A) scores plot; (B) loadings plot resulting from the SRV
analysis; and (C) model validation resulting from 1000 permutations,
demonstrating the model robustness, because model R2 and Q2 values were significantly
higher than random model ones. OPLS model discriminating eat-2(ad465) young adults and eat-2(ad465) adults (1 predictive
component and 2 orthogonal components; R2X = 0.728, R2Y = 0.978, Q2 = 0.934) from
Pareto-scaled data set: (D) scores plot; (E) corresponding loadings
plot resulting from the SRV analysis; and (F) model validation resulting
from 1000 permutations, demonstrating the model robustness. Key: 1,
cyclic fatty acids; 4, lipids (CH2CH2CO); 5, unsaturated lipids (CH2CH=CH); 6, lipids (CH2CO); 7,
unsaturated lipids (CH=CHCH2CH=CH);
8, glyceryl of lipids; 11, phenylalanine; 12, formate; PCho, phosphocholine;
GPC, glycerophosphocholine.Metabolic variations in WT, slcf-1(tm2258) and eat-2(ad465) worms during aging. (A) PCA including young
adults and adults WT, slcf-1(tm2258), and eat-2(ad465). PC1 and PC2 stand for the first and second
principal components, respectively. (B) Relative concentrations in
arbitrary units of 22 metabolites and lipid signals corresponding
to specific chemical functions. Results are reported with means and
95% confidence intervals.
Dietary Restriction Prevents Metabolic Changes Associated with
Aging
Several DR protocols have been tested in C. elegans, such as bacterial dilution on solid or
liquid medium, food deprivation, eat-2 mutants, etc.
However, the extension of lifespan requires the activation of specific
effectors that only partially overlaps between DR regimen.[22,23]The slcf-1 gene encodes a putative monocarboxylate
transporter expressed in the intestine of the worm, and we have recently
shown that the slcf-1(tm2258) mutation increased
longevity by mechanisms similar to DR.[8] We thus asked whether the difference in the metabolic shift observed
with age between WT and slcf-1(tm2258) mutants was
specific for slcf-1(tm2258) mutants or may be a paradigm
for metabolic changes that take place in response to DR. To this end,
we aimed to validate these results by using eat-2(ad465) mutants as a second genetic model of DR, which also exhibit an increased
longevity.[7] The eat-2 gene
encodes a subunit of nicotinic acetylcholine receptors that regulates
pharyngeal pumping. The dramatically reduced frequency of these receptors
in eat-2(ad465) mutants induces a strong reduction
in food intake. PCA showed a distinct cluster for eat-2(ad465) mutants and a discrimination between eat-2(ad465) YA and A7 (Figure 5A) confirmed by supervised
analysis (Figure 4D–F, SI Table S2). PCA also revealed a common axis for discrimination
between YA and A7 in the three strains, but with less amplitude for
the two long-lived mutants. To further evaluate how long-lived mutants
behave along the metabolic coordinates of WT, we projected slcf-1(tm2258) and eat-2(ad465) individuals
onto an OPLS model discriminating YA and A7 WT worms (Figure 2D). YA, for both slcf-1(tm2258) and eat-2(ad465) mutants, cluster with the WT YA
worms, whereas long-lived A7 adults of these long-lived mutants are
projected at an intermediate position on the physiological aging axis,
between YA and A7 WT worms. Overall, these results show that there
are fewer differences between old and young long-lived worms for metabolic
variations associated with physiological aging than between young
and old WT worms and suggest that the metabolic reprogramming triggered
by DR specifically prevents the age-associated metabolic variations.To further investigate this hypothesis, we sought to define metabolites
that discriminate the A7 from YA wild-type worm populations. We identified
a set of metabolites for which concentrations increase with age: saturated
and unsaturated lipids, glycerophosphocholine (GPC), phosphocholine
(PCho), glutamine, and glycine. Another 14 metabolites for which a
decrease in concentration was observed includes a range of amino acids
(alanine, arginine, isoleucine, leucine, lysine, phenylalanine, tyrosine,
valine), formate and cystathionine, both of which are linked to folate
metabolism, as well as tricarboxylic acid cycle (TCA) metabolites
(glutamate, acetate, and lactate) and glycerol (Figures 3 and 5B, SI Table S1). When considering specifically the metabolites that show
age-dependent significant variation in their levels for WT worms,
we observed lower basal levels of lipids and PCho in slcf-1(tm2258) mutants at the YA stage and only a moderate increase with age (Figures 4B, 5B, SI Tables S1 and S3). An attenuated decrease in the concentration
of alanine, arginine, phenylalanine, tyrosine, cystathionine, and
formate was also observed for slcf-1(tm2258) aging
animals, as compared with WT (Figure 4B). Furthermore,
a set of common metabolic features clearly discriminated both eat-2(ad465) and slcf-1(tm2258) animals
from the WT worms. These differences include lower levels of lipids,
leucine, PCho, trehalose, and higher levels of lysine, arginine, and
cystathionine (Figure 5B, SI Table S3). These metabolites may therefore constitute a
common signature of the long-life phenotype for C.
elegans DR mutants.Previous studies[2−6] do not allow one to draw a list of common metabolic variations associated
with DR in aged animals, most probably as a result of different experimental
conditions regarding both sample preparation (nature of biofluid,
age, DR and ad libitum regimen) and analysis (extraction condition,
NMR or MS analysis). Yet, one common observation is that DR counteracts
the increase in lipids associated with age that we also observed in
our study.
High Phosphocholine Content Is Predictive
of a Short Lifespan
Expectancy
These observations show that DR is associated
with a metabolic reprogramming associated with the attenuation of
the metabolic variations linked to physiological aging observed in
worms fed ad libitum and that this effect could participate in the
beneficial effect of DR on lifespan. A mutation that suppresses the
extended lifespan phenotype of DR worms should thus affect the same
metabolite levels in an opposite manner. To test this hypothesis,
we used worms carrying the daf-18(e1375) mutation,
which shortens the average lifespan by 30% compared with WT, while
it completely suppresses the extended longevity of slcf-1(tm2258) worms, as daf-18(e1375);slcf-1(tm2258) double mutants exhibit a lifespan reduced by 60% compared to slcf-1(tm2258) single mutants.[8,24]We analyzed
the metabolome of short-lived daf-18(e1375) and daf-18(e1375); slcf-1(tm2258) mutants and
identified leucine, PCho and arginine as metabolites, the levels of
which vary in the opposite direction in double daf-18(e1375); and slcf-1(tm2258) mutants compared with slcf-1(tm2258) and eat-2(ad465) single
mutants (SI Table S4). Among these metabolites,
we then defined leucine and PCho as metabolites of which levels vary
in the same direction as in short-lived daf-18(e1375) single mutants when compared with WT. Leucine levels decrease with
age and are significantly lower in slcf-1 and eat-2 mutants as compared with WT, and the levels are higher
in daf-18(e1375) single mutants. However, leucine
levels in daf-18(e1375);slcf-1(tm2258) double mutants remain similar to the level of WT animals at day
7 of adulthood (SI Figure S1) and, thus,
do not correlate with life expectancy because daf-18(e1375);slcf-1(tm2258) animals are short-lived compared
with WT.[8]On the other hand, PCho
levels, which are lower in both A7 eat-2(ad465) and slcf-1(tm2258) mutants
compared with WT (Figure 5B), are dramatically
increased in daf-18(e1375) single mutants and daf-18(e1375);slcf-1(tm2258) double mutants
(Figure 6A, SI Table
S4 and S5).
Figure 6
Activation of the phosphocholine pathway with aging. (A) Relative
concentrations in arbitrary units of phosphocholine in young and 7-day-old
adult WT, slcf-1(tm2258), daf-18(e1375), and daf-18(e1375);slcf-1(tm2258) double mutants. Results are reported with means and 95% confidence
intervals. (B) Relative concentrations in arbitrary units of ckb-2 mRNA in young and 7-day-old adults WT, slcf-1(tm2258), daf-18(e1375) and daf-18(e1375);slcf-1(tm2258) double mutants. Results are reported
with means and standard deviations. See SI Table S2 for detailed data and statistical tests for comparison.
(C) Survival curves of OLB11 worms fed control (HT) or ckb-2RNAi bacterial clones. OLB11 strain allows RNAi inactivation of genes
in the intestine only. Data from three independent experiments have
been pooled. The corresponding lifespans were 23.3 ± 0.2 (n = 208) and 19.9 ± 0.4 (n = 228),
respectively, for wild-type and ckb-2RNAi-treated
worms. Comparison with log rank test: p < 10–3.
Activation of the phosphocholine pathway with aging. (A) Relative
concentrations in arbitrary units of phosphocholine in young and 7-day-old
adult WT, slcf-1(tm2258), daf-18(e1375), and daf-18(e1375);slcf-1(tm2258) double mutants. Results are reported with means and 95% confidence
intervals. (B) Relative concentrations in arbitrary units of ckb-2 mRNA in young and 7-day-old adults WT, slcf-1(tm2258), daf-18(e1375) and daf-18(e1375);slcf-1(tm2258) double mutants. Results are reported
with means and standard deviations. See SI Table S2 for detailed data and statistical tests for comparison.
(C) Survival curves of OLB11 worms fed control (HT) or ckb-2RNAi bacterial clones. OLB11 strain allows RNAi inactivation of genes
in the intestine only. Data from three independent experiments have
been pooled. The corresponding lifespans were 23.3 ± 0.2 (n = 208) and 19.9 ± 0.4 (n = 228),
respectively, for wild-type and ckb-2RNAi-treated
worms. Comparison with log rank test: p < 10–3.To further investigate
whether the PCho level may be a valid lifespan
predictor, we calculated the Pearson correlation coefficients between
those two parameters (SI Table S6). We
obtained correlation values of −0.56 (p =
0.296) for YA and −0.83 (p = 0.077) for A7
worms. Correlation coefficients were also calculated considering lifespan
as a qualitative variable (1 for short-lived daf-18(e1375) and daf-18(e1375);slcf-1(tm2258) mutants, 2 for WT, and 3 for long-lived slcf-1(tm2258) and eat-2(ad465) mutants). We obtained correlation
values of −0.45 (p = 0.44) for YA and −0.88
(p = 0.046) for A7 worms. Overall, these results
showed an association between lifespan and PCho level that increased
with age. This association was statistically significant at A7 when
considering lifespan as a qualitative variable. The PCho level measured
for 7-day-old adults was thus a valuable predictor for longevity.It is noteworthy that this observation is not restricted to long-lived
DR worms. It was recently reported that long-lived insulin/IGF-1/daf-2 mutants also harbor lower levels of PCho (among other
metabolic changes) compared with WT[25,26] and that this
level is increased in short-lived FOXO/daf-16 single or daf-16;daf-2 double mutants.[25]
Ckb-2 Choline Kinase Expression Correlates with Physiological
Age and Its Inhibition Decreases Lifespan
PCho is produced
by the phosporylation of choline by choline kinase. To test the hypothesis
that variations in PCho levels may reflect the activation of choline
kinase expression, we quantified choline kinase transcripts in WT
and lifespan mutants at different ages. The C. elegans genome encodes 4 choline kinases called CKB-1, -2, -3, and -4.[27] Although the levels of expression of ckb-1, -3, and -4 do not vary significantly
(Table 1), ckb-2 transcript
levels correlate with PCho content in worms for all genotypes and
ages (Figure 6B). Moreover, living animals
expressing the green fluorescent protein under the control of the ckb-2 endogenous promoter[13] showed
similar age- and genotype-dependent variations in intestinal GFP expression
(data not shown). These data are consistent with the abundance of
PCho being correlated with the activation of the choline pathway with
age.
Table 1
Relative Concentrations in Arbitrary
Units of ckb-1, ckb-2, ckb-4 mRNA in young and 7-day-old adults WT, slcf-1(tm2258), daf-18(e1375), and daf-18(e1375);slcf-1(tm2258) double mutantsa
genotype/age
av level
of mRNA ± SEM
no. replicates
Mann–Whitney
test P values against specific groups
ckb-1
WT/YA
0.99 ± 0.02
6
WT/A7
0.8 ± 0.08
6
0.092/WT YA
slcf-1/YA
0.95 ± 0.08
6
0.575/WT YA
slcf-1/A7
0.87 ± 0.09
6
0.575/slcf-1 YA
0.810/WT A7
daf-18/YA
0.97 ±
0.06
6
0.936/WT YA
daf-18/A7
1.14 ± 0.09
6
0.230/daf-18 YA
0.031/WT A7
daf-18;slcf-1/YA
0.93 ± 0.05
6
0.470/WT YA
1.000/slcf-1 YA
0.936/daf-18 YA
daf-18;slcf-1/A7
1.03 ± 0.11
6
0.093/WT A7
0.575/slcf-1 A7
0.378/daf-18 A7
ckb-2
WT/YA
0.97 ± 0.02
9
WT/A7
2.88 ± 0.32
9
<10–3/WT YA
slcf-1 /YA
0.70 ± 0.04
9
10–3/WT
YA
slcf-1/A7
1.64 ± 0.17
9
<10–3/slcf-1 YA
0.002/WT A7
daf-18/YA
1.03 ±
0.07
6
0.593/WT YA
daf-18 /A7
4.70 ± 0.25
6
0.005/daf-18 YA
0.008/WT A7
daf-18;slcf-1/YA
0.83 ± 0.07
9
0.013/WT YA
0.143/slcf-1 YA
0.045/daf-18 YA
daf-18;slcf-1/A7
5.78 ± 0.64
9
0.020/WT A7
<10–3/slcf-1 A7
0.376/daf-18 A7
ckb-4
WT/YA
0.96 ± 0.06
6
WT/A7
0.8 ± 0.04
6
0.030/WT YA
slcf-1/YA
1.04 ±
0.08
6
0.065/WT YA
slcf-1/A7
0.74 ± 0.05
6
0.013/slcf-1 YA
0.298/WT A7
daf-18/YA
0.81 ± 0.04
6
0.065/WT YA
daf-18 /A7
0.86 ± 0.11
6
1.000/daf-18 YA
0.936/WT A7
daf-18;slcf-1/YA
1.12 ± 0.13
6
0.470/WT YA
1.000/slcf-1 YA
0.020/daf-18 YA
daf-18;slcf-1/A7
0.094 ± 0.1
6
0.471/WT A7
0.128/slcf-1 A7
0.689/daf-18 A7
The C. elegans genome encodes four choline kinase “B”
isoforms named ckb-1, -2, -3, and -4 for which expression data are
reported in the table,
except for ckb-3, which was expressed at undetectable
levels.
The C. elegans genome encodes four choline kinase “B”
isoforms named ckb-1, -2, -3, and -4 for which expression data are
reported in the table,
except for ckb-3, which was expressed at undetectable
levels.We next addressed
the functional significance of these variations.
Choline kinase expression can also be activated during conditions
of endoplasmic reticulum (ER) stress in both worms and mammalian cells,[28−30] and modulation of ER stress response in the intestine was recently
shown to regulate aging.[31] The increased ckb-2 expression in older animals may point to a role for
CKB-2 in adaptation to stress that accumulates with age and predicts
that its inactivation would shorten lifespan. Results presented in
Figure 6C are consistent with this hypothesis.
Although inactivation of ckb-2 at the whole organism
level by RNAi or mutation did not affect lifespan, its inactivation
exclusively in the intestine did significantly shorten C. elegans lifespan. This also suggests that whole
body inactivation of ckb-2 triggers compensation
mechanisms that are not set up when ckb-2 is inactivated
in the intestine only.Our results support the hypothesis that
the phosphocholine level
constitutes a signature of ER stress with age and that low phosphocholine
content reflects higher resistance to ER stress, as we observed for
long-lived slcf-1 mutants (data not shown).
Conclusion
Overall, our data show that metabolic variations take place as
an early step during adulthood, before strong physiological decline
arises. Some of the metabolic variation is counteracted by mutations
that extend lifespan by mimicking DR, supporting the hypothesis that
DR increases lifespan, at least in part, by buffering some metabolic
variations associated with age. Comparisons of the metabolic profiles
obtained from WT, long-lived, and short-lived mutants allowed us to
identify PCho as a potential marker of aging in C.
elegans.Future efforts should concentrate on
new technological approaches
to scale down the number of worms required and thus address the question
of metabolic modifications associated with different ages and genetic
backgrounds in a more systematic manner. Still interestingly, several
recent studies have reported the modification with age of choline
metabolites in different species, including humans.[4,5,32−34] In support of those
observations, our work reinforces the value of metabolomic approaches
to identify new potential biomarkers of aging by further demonstrating
a functional link between phosphocholine levels, choline kinase expression,
and longevity.
Authors: Jennifer M De Guzman; Ginger Ku; Ryan Fahey; Yun-Hee Youm; Ignatius Kass; Donald K Ingram; Vishwa Deep Dixit; Indu Kheterpal Journal: Age (Dordr) Date: 2012-06-04
Authors: Marcella Calfon; Huiqing Zeng; Fumihiko Urano; Jeffery H Till; Stevan R Hubbard; Heather P Harding; Scott G Clark; David Ron Journal: Nature Date: 2002-01-03 Impact factor: 49.962
Authors: Riekelt H Houtkooper; Carmen Argmann; Sander M Houten; Carles Cantó; Ellen H Jeninga; Pénélope A Andreux; Charles Thomas; Raphaël Doenlen; Kristina Schoonjans; Johan Auwerx Journal: Sci Rep Date: 2011-10-31 Impact factor: 4.379
Authors: Anisha Wijeyesekera; Colin Selman; Richard H Barton; Elaine Holmes; Jeremy K Nicholson; Dominic J Withers Journal: J Proteome Res Date: 2012-02-27 Impact factor: 4.466
Authors: Zhonghao Yu; Guangju Zhai; Paula Singmann; Ying He; Tao Xu; Cornelia Prehn; Werner Römisch-Margl; Eva Lattka; Christian Gieger; Nicole Soranzo; Joachim Heinrich; Marie Standl; Elisabeth Thiering; Kirstin Mittelstraß; Heinz-Erich Wichmann; Annette Peters; Karsten Suhre; Yixue Li; Jerzy Adamski; Tim D Spector; Thomas Illig; Rui Wang-Sattler Journal: Aging Cell Date: 2012-08-27 Impact factor: 9.304
Authors: Neil Copes; Clare Edwards; Dale Chaput; Mariam Saifee; Iosif Barjuca; Daniel Nelson; Alyssa Paraggio; Patrick Saad; David Lipps; Stanley M Stevens; Patrick C Bradshaw Journal: Exp Gerontol Date: 2015-09-21 Impact factor: 4.032
Authors: Ryan O Walters; Esperanza Arias; Antonio Diaz; Emmanuel S Burgos; Fangxia Guan; Simoni Tiano; Kai Mao; Cara L Green; Yungping Qiu; Hardik Shah; Donghai Wang; Adam D Hudgins; Tahmineh Tabrizian; Valeria Tosti; David Shechter; Luigi Fontana; Irwin J Kurland; Nir Barzilai; Ana Maria Cuervo; Daniel E L Promislow; Derek M Huffman Journal: Cell Rep Date: 2018-10-16 Impact factor: 9.423
Authors: Andrea Annibal; Rebecca George Tharyan; Maribel Fides Schonewolff; Hannah Tam; Christian Latza; Markus Max Karl Auler; Adam Antebi Journal: Nat Commun Date: 2021-06-09 Impact factor: 14.919
Authors: Monica Ferro; Franca Castiglione; Carlo Punta; Lucio Melone; Walter Panzeri; Barbara Rossi; Francesco Trotta; Andrea Mele Journal: Beilstein J Org Chem Date: 2014-11-19 Impact factor: 2.883
Authors: Arwen W Gao; Iliana A Chatzispyrou; Rashmi Kamble; Yasmine J Liu; Katharina Herzog; Reuben L Smith; Henk van Lenthe; Martin A T Vervaart; Arno van Cruchten; Angela C Luyf; Antoine van Kampen; Mia L Pras-Raves; Frédéric M Vaz; Riekelt H Houtkooper Journal: Sci Rep Date: 2017-05-25 Impact factor: 4.379